AI-generated summary
The authors developed a nanoparticle-enabled, fluorescence-guided transbronchial photothermal therapy for peripheral lung cancer and tested it in mice with three human lung cancer types and in rabbits. They report that systemically given porphysome nanoparticles accumulated in lung tumors with enhanced contrast, improved treatment efficacy, and selective tumor ablation in the rabbit model. The studies were conducted in animals only.
- Who or what was studied
- Mice with orthotopic human lung cancer xenografts (A549, H460, H520) and rabbits with orthotopic VX2 tumors
- Limits stated in the abstract
- All findings come from preclinical animal models, and the abstract does not report human data.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on aacrjournals.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.